Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Optimization of a Roche cobas® Utility Channel Assay for Borrelia species on the Applied Biosystems 7500 qPCR Instrument

ASM DC Branch Spring Meeting 2025

American Society for Microbiology

Washington, DC  Apr 25, 2025

Oral presentation: Optimization of a Roche cobas® Utility Channel Assay for Borrelia species on the Applied Biosystems 7500 qPCR Instrument

Authors: Harpole MG, Hughes LJ, Starolis MW

Medical Specialty: Infectious disease, Internal Medicine

Related content

On-Demand Webinar
Tick-borne Illness A Panel Discussion About Emerging Diagnostics Insights
Conference Presentation
Performance of the Roche cobas® HIV-1/2 Qualitative Assay in Whole Blood with Proviral HIV-1 DNA
Publication
A Comparison of Lyme Serological Testing Platforms with a Panel of Clinically Characterized Samples from Various Stages of Lyme Disease
Publication
Utility of Whole Blood Real-Time PCR Testing for the Diagnosis of Early Lyme Disease
Conference Presentation
Tick-Borne Disease Molecular Testing Positivity and Coinfection Incidence in the Northeastern United States: 2021-2023

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.